127 related articles for article (PubMed ID: 38147832)
1. Dapagliflozin Ameliorates Ovulation Disorders via Attenuating Activated Microglia-Mediated Hypothalamic Inflammation in HFD-Fed Mice.
Chen X; Xiao Z; Liu Q; Luo D; Cai Y; Fan M
Neuroendocrinology; 2024; 114(4):331-347. PubMed ID: 38147832
[TBL] [Abstract][Full Text] [Related]
2. Renal outcomes with sodium glucose cotransporter 2 (SGLT2) inhibitor, dapagliflozin, in obese insulin-resistant model.
Jaikumkao K; Pongchaidecha A; Chueakula N; Thongnak L; Wanchai K; Chatsudthipong V; Chattipakorn N; Lungkaphin A
Biochim Biophys Acta Mol Basis Dis; 2018 Jun; 1864(6 Pt A):2021-2033. PubMed ID: 29572114
[TBL] [Abstract][Full Text] [Related]
3. Leptin and inflammatory factors play a synergistic role in the regulation of reproduction in male mice through hypothalamic kisspeptin-mediated energy balance.
Chang B; Song C; Gao H; Ma T; Li T; Ma Q; Yao T; Wang M; Li J; Yi X; Tang D; Cao S
Reprod Biol Endocrinol; 2021 Jan; 19(1):12. PubMed ID: 33472656
[TBL] [Abstract][Full Text] [Related]
4. Dapagliflozin and Ticagrelor Have Additive Effects on the Attenuation of the Activation of the NLRP3 Inflammasome and the Progression of Diabetic Cardiomyopathy: an AMPK-mTOR Interplay.
Chen H; Tran D; Yang HC; Nylander S; Birnbaum Y; Ye Y
Cardiovasc Drugs Ther; 2020 Aug; 34(4):443-461. PubMed ID: 32335797
[TBL] [Abstract][Full Text] [Related]
5. Empagliflozin Ameliorates Obesity-Related Cardiac Dysfunction by Regulating Sestrin2-Mediated AMPK-mTOR Signaling and Redox Homeostasis in High-Fat Diet-Induced Obese Mice.
Sun X; Han F; Lu Q; Li X; Ren D; Zhang J; Han Y; Xiang YK; Li J
Diabetes; 2020 Jun; 69(6):1292-1305. PubMed ID: 32234722
[TBL] [Abstract][Full Text] [Related]
6. The SGLT-2 Inhibitor Dapagliflozin Has a Therapeutic Effect on Atherosclerosis in Diabetic ApoE
Leng W; Ouyang X; Lei X; Wu M; Chen L; Wu Q; Deng W; Liang Z
Mediators Inflamm; 2016; 2016():6305735. PubMed ID: 28104929
[No Abstract] [Full Text] [Related]
7. Dapagliflozin ameliorates pancreatic injury and activates kidney autophagy by modulating the AMPK/mTOR signaling pathway in obese rats.
Jaikumkao K; Promsan S; Thongnak L; Swe MT; Tapanya M; Htun KT; Kothan S; Intachai N; Lungkaphin A
J Cell Physiol; 2021 Sep; 236(9):6424-6440. PubMed ID: 33559163
[TBL] [Abstract][Full Text] [Related]
8. SGLT2-inhibitor and DPP-4 inhibitor improve brain function via attenuating mitochondrial dysfunction, insulin resistance, inflammation, and apoptosis in HFD-induced obese rats.
Sa-Nguanmoo P; Tanajak P; Kerdphoo S; Jaiwongkam T; Pratchayasakul W; Chattipakorn N; Chattipakorn SC
Toxicol Appl Pharmacol; 2017 Oct; 333():43-50. PubMed ID: 28807765
[TBL] [Abstract][Full Text] [Related]
9. SGLT2 inhibitor counteracts NLRP3 inflammasome via tubular metabolite itaconate in fibrosis kidney.
Ke Q; Shi C; Lv Y; Wang L; Luo J; Jiang L; Yang J; Zhou Y
FASEB J; 2022 Jan; 36(1):e22078. PubMed ID: 34918381
[TBL] [Abstract][Full Text] [Related]
10. SGLT2 Inhibition by Empagliflozin Promotes Fat Utilization and Browning and Attenuates Inflammation and Insulin Resistance by Polarizing M2 Macrophages in Diet-induced Obese Mice.
Xu L; Nagata N; Nagashimada M; Zhuge F; Ni Y; Chen G; Mayoux E; Kaneko S; Ota T
EBioMedicine; 2017 Jun; 20():137-149. PubMed ID: 28579299
[TBL] [Abstract][Full Text] [Related]
11. Sodium-glucose cotransporter 2 inhibitor ameliorates high fat diet-induced hypothalamic-pituitary-ovarian axis disorders.
Chen X; Huang L; Cui L; Xiao Z; Xiong X; Chen C
J Physiol; 2022 Nov; 600(21):4549-4568. PubMed ID: 36048516
[TBL] [Abstract][Full Text] [Related]
12. Leptin deficiency and diet-induced obesity reduce hypothalamic kisspeptin expression in mice.
Quennell JH; Howell CS; Roa J; Augustine RA; Grattan DR; Anderson GM
Endocrinology; 2011 Apr; 152(4):1541-50. PubMed ID: 21325051
[TBL] [Abstract][Full Text] [Related]
13. Red raspberries suppress NLRP3 inflammasome and attenuate metabolic abnormalities in diet-induced obese mice.
Zhu MJ; Kang Y; Xue Y; Liang X; García MPG; Rodgers D; Kagel DR; Du M
J Nutr Biochem; 2018 Mar; 53():96-103. PubMed ID: 29202274
[TBL] [Abstract][Full Text] [Related]
14. Modulation of Sirt1 and FoxO1 on Hypothalamic Leptin-Mediated Sympathetic Activation and Inflammation in Diet-Induced Obese Rats.
Liu X; Zheng H
J Am Heart Assoc; 2021 Jul; 10(14):e020667. PubMed ID: 34259031
[TBL] [Abstract][Full Text] [Related]
15. The Sodium-Glucose Cotransporter 2 Inhibitor Dapagliflozin Prevents Renal and Liver Disease in Western Diet Induced Obesity Mice.
Wang D; Luo Y; Wang X; Orlicky DJ; Myakala K; Yang P; Levi M
Int J Mol Sci; 2018 Jan; 19(1):. PubMed ID: 29301371
[TBL] [Abstract][Full Text] [Related]
16. Canagliflozin, a sodium glucose cotransporter 2 inhibitor, attenuates obesity-induced inflammation in the nodose ganglion, hypothalamus, and skeletal muscle of mice.
Naznin F; Sakoda H; Okada T; Tsubouchi H; Waise TM; Arakawa K; Nakazato M
Eur J Pharmacol; 2017 Jan; 794():37-44. PubMed ID: 27876617
[TBL] [Abstract][Full Text] [Related]
17. Downregulation of leptin receptor and kisspeptin/GPR54 in the murine hypothalamus contributes to male hypogonadism caused by high-fat diet-induced obesity.
Zhai L; Zhao J; Zhu Y; Liu Q; Niu W; Liu C; Wang Y
Endocrine; 2018 Oct; 62(1):195-206. PubMed ID: 29948931
[TBL] [Abstract][Full Text] [Related]
18. Microglia Sirt6 modulates the transcriptional activity of NRF2 to ameliorate high-fat diet-induced obesity.
Xiao X; Hu H; Zhong Y; Chen Y; Tang K; Pan Z; Huang J; Yang X; Wang Q; Gao Y
Mol Med; 2023 Aug; 29(1):108. PubMed ID: 37582706
[TBL] [Abstract][Full Text] [Related]
19. A casein hydrolysate protects mice against high fat diet induced hyperglycemia by attenuating NLRP3 inflammasome-mediated inflammation and improving insulin signaling.
Healy NP; Kirwan AM; McArdle MA; Holohan K; Nongonierma AB; Keane D; Kelly S; Celkova L; Lyons CL; McGillicuddy FC; Finucane OM; Murray BA; Kelly PM; Brennan L; FitzGerald RJ; Roche HM
Mol Nutr Food Res; 2016 Nov; 60(11):2421-2432. PubMed ID: 27390025
[TBL] [Abstract][Full Text] [Related]
20. Empagliflozin reverses obesity and insulin resistance through fat browning and alternative macrophage activation in mice fed a high-fat diet.
Xu L; Nagata N; Chen G; Nagashimada M; Zhuge F; Ni Y; Sakai Y; Kaneko S; Ota T
BMJ Open Diabetes Res Care; 2019; 7(1):e000783. PubMed ID: 31749970
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
